Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1989-2-21
|
pubmed:language |
rus
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0038-5077
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
9-12
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3212565-Aged,
pubmed-meshheading:3212565-Coronary Disease,
pubmed-meshheading:3212565-Female,
pubmed-meshheading:3212565-Heart Failure,
pubmed-meshheading:3212565-Humans,
pubmed-meshheading:3212565-Hydralazine,
pubmed-meshheading:3212565-Male,
pubmed-meshheading:3212565-Middle Aged,
pubmed-meshheading:3212565-Valsalva Maneuver,
pubmed-meshheading:3212565-Vasodilator Agents
|
pubmed:year |
1988
|
pubmed:articleTitle |
[The effect of apressin on the results of the Valsalva test in ischemic heart disease].
|
pubmed:publicationType |
Journal Article,
English Abstract
|